|
Video: What is a Stock Split?
|
|
Cerulean Pharma is a clinical-stage, oncology-focused company applying its proprietary Dynamic Tumor Targeting Platform to develop various therapies. Co.'s platform is designed to create nanoparticle-drug conjugates, which consist of anti-cancer therapeutics, or payloads, covalently linked to a proprietary polymer. Co.'s principal clinical candidate, CRLX101, is in Phase 2 clinical development in patients with renal cell carcinoma and in Phase 2 and Phase 1b clinical development in patients with ovarian cancer in combination with Avastin® (bevacizumab) and paclitaxel, respectively. Co.'s second clinical candidate, CRLX301, is in Phase 1/2a clinical development. According to our CERU split history records, CERU has had 1 split. | |
|
CERU (CERU) has 1 split in our CERU split history database. The split for CERU took place on July 20, 2017. This was a 1 for 10 reverse split, meaning for each 10 shares of CERU owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as CERU conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the CERU split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into CERU shares, starting with a $10,000 purchase of CERU, presented on a split-history-adjusted basis factoring in the complete CERU split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
12/16/2014 |
|
End date: |
07/20/2017 |
|
Start price/share: |
$61.50 |
|
End price/share: |
$6.56 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-89.33% |
|
Average Annual Total Return: |
-57.83% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$1,066.82 |
|
Years: |
2.59 |
|
|
|
Date |
Ratio |
07/20/2017 | 1 for 10 |
|
|